On Wednesday, UBS reaffirmed its Buy rating on Nutrien Ltd (NYSE:NTR), maintaining a $67.00 price target for the company's stock. The firm's stance comes after Nutrien's investor day, which highlighted the company's emphasis on modest portfolio optimization and improved internal efficiency. These steps aim to enhance returns and cash conversion for the agriculture input provider.
Nutrien's perspective on its mid-cycle earnings before interest, taxes, depreciation, and amortization (EBITDA) potential remains consistent at approximately $7.25 billion, utilizing mostly existing capacity. However, UBS suggests that a 10-year average price scenario, which estimates EBITDA at around $6 billion, may be more fitting. This figure exceeds consensus projections by about 10% for the years 2025 and 2026, according to UBS estimates (UBSe). The disparity is attributed to a roughly $20 per metric ton difference in price basis, excluding the peak pricing witnessed around 2022.
The firm also noted the significant role of growing EBITDA from Nutrien's Retail segment, which is currently recovering from depressed levels. This growth is expected to contribute to an improvement in the company's return on invested capital (ROIC). Additionally, targeted smaller fertilizer investments, such as mining automation and brownfield nitrogen projects, along with supply chain efficiency improvements, are anticipated to bolster this metric.
UBS finds Nutrien shares to be appealing due to their higher relative free cash flow (FCF) yield. The firm also expresses a more optimistic outlook on the potash and retail sectors within the agricultural industry, which are key components of Nutrien's business model.
In other recent news, Nutrien Ltd. has outlined its growth strategy and performance targets, aiming to enhance shareholder value over the long term. The company plans to streamline its portfolio, focus on core assets and markets, and increase efficiency through automation and operational excellence initiatives. Nutrien has also set goals to increase potash and nitrogen sales volumes by 2.0 to 3.0 million tonnes by 2026 from 2023 levels and target a reduction of approximately $200 million by 2026 across operations and corporate functions.
On the analyst front, Nutrien has been the subject of several assessments. Jefferies maintained a Buy rating on Nutrien, citing a steady market for the company's products based on their potash model. Piper Sandler, however, maintained an "Underweight" rating due to potential challenges from an anticipated large US corn crop. RBC Capital Markets maintained an "Outperform" rating, indicating confidence in Nutrien's operational efficiency and improved cash generation.
Additionally, Nutrien's first-quarter performance in 2024 saw a $1.1 billion adjusted EBITDA, despite decreased earnings due to lower benchmark prices for potash, nitrogen, and phosphate. The company achieved higher sales volumes and reduced operating costs. These are recent developments that potential investors should consider when evaluating Nutrien's prospects.
InvestingPro Insights
Following UBS's endorsement of Nutrien Ltd (NYSE:NTR) with a maintained Buy rating and a $67.00 price target, InvestingPro metrics present a nuanced picture of the company's financial health and market position. With a substantial market capitalization of $25.81 billion and a current P/E ratio of 30.76, Nutrien shows the characteristics of a prominent player in the Chemicals industry, as indicated by an InvestingPro Tip. The adjusted P/E ratio for the last twelve months as of Q1 2024 stands at a lower 18.17, suggesting a more favorable valuation when considering the company's earnings over a more recent period. Moreover, Nutrien's dividend yield as of mid-2024 is notable at 4.06%, underscoring its track record of having raised its dividend for six consecutive years—a fact that income-focused investors might find particularly attractive.
Despite a year-over-year revenue decline of 22.95% in the last twelve months as of Q1 2024, Nutrien's gross profit margin remains healthy at 29.64%. This demonstrates the company's ability to maintain profitability margins even in challenging market conditions. Additionally, analysts predict profitability for the current year, an InvestingPro Tip that aligns with UBS's positive outlook on the company's EBITDA potential and free cash flow yield.
For those considering an investment in Nutrien, or seeking deeper analysis, InvestingPro offers additional tips on the company's prospects. With the special coupon code PRONEWS24, readers can access these insights at a discounted rate on a yearly or biyearly Pro and Pro+ subscription, providing a comprehensive understanding of Nutrien's investment potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.